Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 11.54 | N/A |
PEG Ratio (TTM) | 0.98 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | -6.88 | N/A |
P/FCF Ratio (TTM) | -119.24 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.73% | N/A |
ROE (TTM) | 5.25% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 14.72% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -18.23% | N/A | N/A |
Cash Flow | -29.46% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.09 | N/A |
Quick Ratio (TTM) | 0.09 | N/A |
D/E Ratio (TTM) | -0.34 | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | 13.48 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |